Navigation Links
MaxCyte to Present at the Phacilitate Cell and Gene Therapy Forum 2008
Date:1/28/2008

GAITHERSBURG, Md., Jan. 28 /PRNewswire-USNewswire/ -- MaxCyte, Inc., a clinical-stage therapeutic company and pioneer in clinical scale, non-viral cell loading systems, announces that Madhusudan V. Peshwa, Ph.D., Vice President Research and Development at MaxCyte, will present on Tuesday, January 29, 2008, at 11:35 AM at the Phacilitate Cell and Gene Therapy Forum in Washington, DC. Dr. Peshwa's presentation entitled "Engineering Cellular Function: A Paradigm Shift in Development and Manufacture of Cellular Therapy," will discuss the development of engineered cell based therapies in the context of clinical experiences in oncology and cardiopulmonary diseases.

About MaxCyte

MaxCyte is a clinical-stage cell therapeutics company with a rapidly growing pipeline of product development partnerships in cell-based therapies. The Company's proprietary, non-viral, ex vivo cell loading technology provides safety, scalability and reproducibility capabilities which are fundamental to commercializing successful cell-based therapies. MaxCyte has demonstrated the value of its versatile technology in partnered therapeutic programs in oncology, pulmonary, metabolic and infectious diseases as well as in development collaborations with leading researchers. Current clinical programs with MaxCyte-engineered cells include: a Phase IIa clinical study for treatment of chronic lymphocytic leukemia (CLL) and a Phase IIa study using engineered stem cells for the treatment of primary Pulmonary Arterial Hypertension (PAH). MaxCyte has recently partnered with Medinet (JP) to commercialize a cell based therapy to be launched in 2008. In addition, there are advanced preclinical programs in oncology and regenerative medicine. More than 16 commercial and academic partners are currently using the MaxCyte technology. The MaxCyte system has an FDA Master File in place at the Center for Biologics Evaluation and Research (CBER).

For more information, visit

SOURCE MaxCyte, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. SXC Health Solutions to present at the 2008 UBS Global Healthcare Services Conference
2. Novadaq Data Presented at 2008 Society of Thoracic Surgeons Meeting
3. Interleukin Genetics, Inc. Management to Present at Healthcare Conferences
4. Weight Watchers to Present at Credit Suisse 10th Annual Global Services Conference
5. Bill Germanakos and Hollie Self Bring The Biggest Loser Million-Pound Tour, Presented by MSN, to Arizona Mills Mall
6. Warner Chilcott to Present at the 2008 Wachovia Healthcare Conference
7. InterMune to Present at the 2008 Wachovia Healthcare Conference
8. Pennsylvania AFL-CIO Decries Shameful Votes Again by Representatives John Peterson, Joe Pitts and Bill Shuster, Against Childrens Health Care
9. Melanomas Present Unique Appearance
10. Susan G. Komen for the Cure Sharing Grassroots Advocacy Knowledge With International Representatives in Intensive Dallas Training Session
11. Illness Presents Diabetics With Special Challenges

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...est rates seen in Central and South America, study...ws) -- About 50 percent of intensive care unit pat...their risk of dying in the hospital, a new study f...a single day (May 8, 2007) on 13,796 patients, age...y found that 51 percent of patients were classifie...
(Date:12/1/2009)...ILADELPHIA (December 1, 2009) Wistar Institute r...f Pennsylvania and New York University have identi...cate early-stage lung tumors in people at high ris...hed online December 1 in Cancer Research , a jour...h, could lead to a simple blood test to detect lun...
(Date:12/1/2009)... , RESEARCH TRIANGLE PARK, N.C., Dec. 1 /P...itiated in 2001 and have expanded over the years s...lly. The facility which was originally set up in a...armacy services, as part of the suite of services ... industry as a valuable offering. ,, The pharma...
(Date:12/1/2009)... , WASHINGTON, Dec. 1 /PRNewswire-USNewswire...CDHPs) are more likely than those with traditional...haviors, to be more engaged in wellness programs, ...centives matter in holding down costs, according t... Employee Benefit Research Institute (EBRI). ,...
(Date:12/1/2009)... , FORT LAUDERDALE, Fla., Dec. 1 /PRNewswir... patient enrollment in the randomized clinical tri...tent (Combo Stent). ,, A prospective, randomize... valuation of an ablu M inal sirolimus coat ED ...tients at up to 20 sites in Asia, Australia, Europ...
Breaking Medicine News(10 mins):Health News:Half of ICU Patients Suffer From Infections 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 2Health News:Wistar-led research team discovers genetic pattern that indicates early-stage lung cancer 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 2Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 3Health News:New Research From EBRI: Consumer-Driven Health Plan Participants Display Cost-Conscious Behavior, Utilize Wellness Programs 4Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 2Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 3Health News:OrbusNeich Announces First Patient Enrolled in REMEDEE, a Randomized Clinical Trial of the Combo Bio-engineered Sirolimus Eluting Stent 4
...l elections in US. The issue is raging in neighbou...ticians to get away with glib talk. As the country...quent on the governments commitment to medicare, a...s need a credit card'' and "Where did medicare go?...
...nxiously awaiting reports later this week on wheth...e deadly viral hemorrhagic septicemia. Of...rces (DNR) confirmed that two fish from an adjoini...ke Butte des Morts is the first occurrence of the ...
...pressed over the housing together of two convicted...rs Robbie Sebastian Wheeler, 43, and his boyfrien...ether in Hakea jail, in West Australia. The t...ed to murder the boy and dispose of his body. ...
...rculosis, researchers say. A study of 131 ...ity of the body to inhibit the growth of the bacte...f BBC News. Until now no study has evaluat...cipants and infected with mycobacteria. Th...
...udents with asthma who participated in a specially...ported fewer days and nights with symptoms, fewer...vity, and less hospitalization for asthma during a...gist for the Henry Ford Health System in Detroit, ...
...stroke in the past two months across Orissa, offic... been reported from the southern district of Ganja...icts of Balasore, Kandhamal, Kendrapada, Nuapada a... from various parts of the state. These are being ...
Other Medicine News:Health News:Cancer Patients Turn Their Backs on Canadian Health Minister 2Health News:Deadly Virus Hits Popular Lake in US 2Health News:Outrage Against Gay PartnersInCrime Kept Together 2Health News:Web-based Asthma Program Improves Disease Management for Black Students 2
(Date:12/1/2009)... Sleep Solutions®, Inc. (SSI),...testing and evaluation of sleep-disordered breathi...M.D., as its chief executive officer. Hassett was...ing its growth from a $250 million healthcare hold... total population health, and its subsequent sale ...
(Date:12/1/2009)...wswire/ -- At this year,s annual meeting of the Ra...Philips Electronics ( PHG, AEX: PHI) will introduc...s that provides radiologists the ability to review...elp drive quality and efficiency. Showcasing its ...ight new capabilities for its portfolio of diagnos...
(Date:12/1/2009)... Exagen Diagnostics, Inc., a molec...ps and markets proprietary genomic tests, today an... of the company,s board of directors and chief exe...nn was managing partner of Windamere Venture Partn...al companies including Prometheus Laboratories, Sa...
Breaking Medicine Technology:Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 2Sleep Solutions, Inc. Names Richard Hassett, M.D., New CEO 3Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 2Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 3Philips Introduces Multi-Modality Breast Workspace to Complement Comprehensive Portfolio of Diagnostic Imaging Solutions for Breast Care 4Scott Glenn Joins Exagen Diagnostics as Chairman and CEO 2The Rasansky Law Firm Announces Dallas Day Care Death Lawsuit 3B State Investigation Finds Evidence of Negligence at Woodbridge Day School 60768 1The Rasansky Law Firm Announces Dallas Day Care Death Lawsuit 3B State Investigation Finds Evidence of Negligence at Woodbridge Day School 60768 2Beike Biotechnology Invests in Leading Japanese Regenerative Medicine Co Biomaster Inc 60766 1Beike Biotechnology Invests in Leading Japanese Regenerative Medicine Co Biomaster Inc 60766 2Beike Biotechnology Invests in Leading Japanese Regenerative Medicine Co Biomaster Inc 60766 3Beike Biotechnology Invests in Leading Japanese Regenerative Medicine Co Biomaster Inc 60766 4Qualsecs Wholly Owned Subsidiary Receives Order From New Jersey Based DMC Athletics and Rehabilitation 60764 1Qualsecs Wholly Owned Subsidiary Receives Order From New Jersey Based DMC Athletics and Rehabilitation 60764 2
...orporated (Nasdaq: VICL ),today is presenting exp...strating that the company,s Vaxfectin(R) adjuvant ...d infectious disease vaccines and,peptide-based ca...Vical,s,Senior Vice President of Product Developme... 8, at the World Vaccine Congress (Lyon, France - ...
...ealth Care and its Great,Lakes Cancer Institute ar...nds to share the latest work underway around the g...nts. The October 11th symposium, hosted by,McLaren..., M.D., an,award-winning surgical oncologist whose...er has gained worldwide recognition and has evolve...
Other Medicine Technology:Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 2Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 3Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 4Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months 5News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: